The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $5.80

Today's change0.00 0.00%
Updated August 27 3:59 PM EDT. Delayed by at least 15 minutes.
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $5.80

Today's change0.00 0.00%
Updated August 27 3:59 PM EDT. Delayed by at least 15 minutes.

BioAmber Inc closed at (U.S.)$5.80.

Over the last five days, shares have lost 7.64% and are down 30.87% for the last year to date. This security has underperformed the S&P 500 by 52.26% during the last year.

Key company metrics

  • Open(U.S.) $5.26
  • Previous close(U.S.) $5.80
  • High(U.S.) $5.83
  • Low(U.S.) $5.26
  • Bid / Ask-- / --
  • YTD % change-30.87%
  • Volume43,202
  • Average volume (10-day)57,847
  • Average volume (1-month)84,405
  • Average volume (3-month)54,482
  • 52-week range(U.S.) $4.64 to (U.S.) $12.76
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.54
Updated August 27 3:59 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-2,487.91%

BioAmber Inc has a net profit margin of -2,487.91%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX2.88%Sector:Basic MaterialsIndustry:Chemicals - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit00-2-1
Total cost of revenue1021
Total operating expense119108
Selling / general / administrative4433
Research & development5544
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)1--10
Other operating expenses, total--------
Operating income-11-8-10-8
Interest income (expense), net non-operating-1000
Gain (loss) on sale of assets--------
Other--------
Income before tax-15-9-5-8
Income after tax-15-9-5-8
Income tax, total0000
Net income-14-8-4-8
Total adjustments to net income--------
Net income before extra. items-14-8-4-8
Minority interest1100
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-14-8-4-8
Inc. avail. to common incl. extra. items-14-8-4-8
Diluted net income-14-8-4-8
Dilution adjustment----00
Diluted weighted average shares24222221
Diluted EPS excluding extraordinary itemsvalue per share-0.58-0.38-0.20-0.39
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.55-0.38-0.18-0.40